SEARCH

SEARCH BY CITATION

Corrigendum to: Endotoxin removal and prevention for pre-clinical biologics production

Serdakowski London, A. et al, Biotechnol. J. 2012, 7, 1509–1516. DOI: 10.1002/biot.201200220

Due to structural changes within Novartis, the corresponding author of this paper neglected to include Jochen Eisfeld on the list of authors. The method described in section 2.4.1. of the paper was developed by Jochen Eisfeld and the results in Fig. 2A. and parts of section 3.2.1 were performed under the supervision of Jochen Eisfeld.

The list of authors and their affiliations should therefore be as follows:

Anne Serdakowski London1, Brendan Kerins2, William R. Tschantz1, Jochen Eisfeld3 and Kasey Mackay1

1 Novartis Institutes for Biomedical Research, Protein Production and Antibodies, Cambridge, MA, USA

2 Novartis Institutes for Biomedical Research, Protein Production and Antibodies, Basel, Switzerland

3 Novartis Pharma AG, Integrated Biologics Profiling, Basel, Switzerland

The authors apologize for any inconvenience caused by this oversight.